***MaxiFlex (Registered)***Multinutrient Formula***Maximum Joint Support***MedOp, Inc.***Dietary Supplement ***120 Vegetable Capsules***D...
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2942-2015.
Maxivision MaxiFlex (Registered) Multinutrient Formula, 120 Vegetable Capsules is being recalled because a material review was conducted in April 2015. It revealed some of the Chondroitin Sulfate (Lot 093011 1031) raw material used in the manufacture of Maxiflex Multinutrient Formula Lot 32171215 was Out of Specification.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2942-2015.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Medop Health, Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-2942-2015.
MedOp Health, Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Medop Health, Inc. Recall FAQ
Medop Health, Inc. is the subject of a produce safety report: ***MaxiFlex (Registered)***Multinutrient Formula***Maximum Joint Support***MedOp, Inc.***Dietary Supplement ***120 Vegetable Capsules***D.... The notice was published on April 30, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 638 units are potentially affected.